FindTrial
Sign In

Changes in hemodynamic responses to laryngoscopy and intubation with three different doses of dexmedetomidine.

Attenuation of hemodynamic responses to laryngoscopy and intubation with three different doses of dexmedetomidine.A randomised prospective controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017816
Enrollment
120
Registered
2019-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H748- Other specified disorders of middle ear and mastoid

Interventions

Intervention1: All the cases will be divided to 4 groups of 30 each ( computer generated randomized number) . : Group A ,Group B, Group C will receive Dexmedetomidine 0.5mcg/kg, 0.75mcg/kg,

Sponsors

Mousumi Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA-I AND II

Exclusion criteria

Exclusion criteria: HYPERTENSION ,DIABETES,COPD, ISCHEMIC HEART DISEASE, PTS ON BETA BLOCKER ,HEART BLOCK,CASES OF BASELINE SINUS BRADYCARDIA,ALLERGY TO STUDY DRUG,BMI >30,PREGNANCY ,DIFFICULT AIRWAYS,EMERGENCY SURGERIES.

Design outcomes

Primary

MeasureTime frame
To find a simple and safe method for diminishing the incidence and severity of cardiovascular reaction to laryngoscopy and tracheal intubation which would be of clinical importance in anaesthetic practice . Timepoint: 15-02-2019 to 14-02-2020—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDr Mousumi Das

Kalinga Institute Of Medical Sciences, Bhubaneswar, Orissa

mousumi.das1503@gmail.com7750847478

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026